IRCT20190210042676N31招募中2 期
Evaluating of safety and efficacy of Stylux REDENSITY ® mesogel (Novajen Daru CO) for improvement of skin hydration and elasticity”
ovajen Daru0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 21 years 至 55 years（—）
- 性别
- All
入选标准
- •Age between 21 and 55years old
- •Present visible signs of skin ageing symptoms mainly skin dryness skin roughness, loss of elasticity and appearance of fine lines
- •Possibility to accompany the visit plans and study process.
- •Signing an informed consent form and agreed to follow up.
排除标准
- •Previous treatment with hyaluronic acid fillers in the facial area within the past year
- •Systemic diseases affecting skin health such as collagen vascular diseases, diabetes, hypothyroidism, as well as liver and renal failure
- •Experience with RF, rejuvenation lasers or intense pulsed light in the past 6 months
- •History of systemic use of skin-related medicine such as glucocorticoids, isotretinoin, immunomodulators and hormonal medicine in the past 3 months
- •Currently pregnant or lactating
- •Smoking in the past two years
研究者
相似试验
招募中
2 期
Evaluating of safety and efficacy of Stylux Voluma dermal fillerIRCT20190210042676N32ovajen Daru30
招募中
不适用
Evaluation of clinical efficacy and safety of sentinel lymph node biopsy using magnetic nanoparticle and magnetic probeBreast cancerJPRN-UMIN000031240Japan Agency for Medical Research and Development180
尚未招募
4 期
This is a randomised study to assess the safety and efficacy of a high dose vitamin D supplement compared to the standard vitamin D therapy in children.Vitamin D deficiencyDiet and Nutrition - Other diet and nutrition disordersACTRN12609000874213The Children's Hospital at Westmead140
已完成
3 期
Evaluation of the effect of acetylene drug in comparison with oral administration of pantoprazole in controlling symptoms of gastro-esophageal reflux.IRCT20180422039378N1Bagheiat-allah University of Medical Sciences60
已完成
不适用
Evaluation of the efficacy and safety of luseogliflozin and changes in QOType 2 diabetes mellitusJPRN-UMIN000023035The Institute for Adult Diseases, Asahi Life Foundation64